Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Wuhan, China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East

  • Sample Provided: no

    Payment Terms: T/T

    Indications:

    • Prevention of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation in assisted reproductive technologies (ART) like in-vitro fertilization (IVF).

    Mechanism of Action: Ganirelix works by competitively blocking the GnRH receptors on the pituitary gland, thus preventing the release of LH and follicle-stimulating hormone (FSH). This inhibition prevents premature ovulation, allowing for more controlled ovarian hyperstimulation.

    Pharmacokinetics:

    • Absorption: Rapidly and almost completely absorbed after subcutaneous administration.
    • Distribution: Rapidly distributed in the body.
    • Metabolism: Mainly hepatic.
    • Excretion: Primarily through the kidneys.

    Form: Ganirelix API is typically presented as a white to off-white lyophilized powder.

Send your message to this supplier
  • From:
  • To:
    HYBIO PHARMACEUTICAL CO., LTD.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service